Certified by Founder Lodge
Centauri Therapeutics Limited
United Kingdom - London
START UP
1 Disclosed Funding Rounds $8,107,170
0 Participating Investments
-
Founded date
2014
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Centauri Therapeutics Limited is a UK-based biotechnology company focused on the discovery and development of novel molecules targeting life threatening diseases.
The Alphamer technology
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| February, 25 ,2026 | Series A | $8,107,170 |
AMR Action Fund
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Leadbay (YC F25) | $4,300,000 | (May 20, 2026)
Rely | $4,500,000 | (May 20, 2026)
Scope AI | $20,000,000 | (May 20, 2026)
Kin Health | $9,000,000 | (May 20, 2026)
